New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Reprogramming cancer cells into immune defenders

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples
Oncology December 26,2023
Reprogramming cancer cells into immune defenders

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples
Oncology December 26,2023
Exposing cancers to bacteria reminds first responder immune cells which side they're on

Exposing cancers to bacteria reminds first responder immune cells which side they're on

byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T
Oncology December 26,2023
Exposing cancers to bacteria reminds first responder immune cells which side they're on

Exposing cancers to bacteria reminds first responder immune cells which side they're on

byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T
Oncology December 26,2023
Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th
Oncology December 26,2023
Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th
Oncology December 26,2023
Identifying the inflammatory cells behind chemo brain

Identifying the inflammatory cells behind chemo brain

by Emily Caldwell,The Ohio State UniversityEffects of chemotherapy on microglia and astrocyte immunohistochemistry. (A) Representative images of Iba-1 immunohistochemistry in the PVN and DG, (B)
Neurology December 26,2023
Identifying the inflammatory cells behind chemo brain

Identifying the inflammatory cells behind chemo brain

by Emily Caldwell,The Ohio State UniversityEffects of chemotherapy on microglia and astrocyte immunohistochemistry. (A) Representative images of Iba-1 immunohistochemistry in the PVN and DG, (B)
Neurology December 26,2023
Social determinants of health affect racial disparity in prostate cancer mortality

Social determinants of health affect racial disparity in prostate cancer mortality

by Elana GotkineWhen accounting for social determinants of health (SDOH), Black men with prostate cancer have lower prostate cancer-specific mortality (PCSM) than White men, according to a systematic
Oncology December 26,2023
Social determinants of health affect racial disparity in prostate cancer mortality

Social determinants of health affect racial disparity in prostate cancer mortality

by Elana GotkineWhen accounting for social determinants of health (SDOH), Black men with prostate cancer have lower prostate cancer-specific mortality (PCSM) than White men, according to a systematic
Oncology December 26,2023
Health inequity may drive higher symptom burden in childhood cancer survivors

Health inequity may drive higher symptom burden in childhood cancer survivors

bySt. Jude Children's Research HospitalMelissa Hudson, M.D., co-author Les Robison, Ph.D., St. Jude Department of Epidemiology and Cancer Control chair, I-Chang Huang, Ph.D., co-author and K
Pediatrics December 26,2023
Health inequity may drive higher symptom burden in childhood cancer survivors

Health inequity may drive higher symptom burden in childhood cancer survivors

bySt. Jude Children's Research HospitalMelissa Hudson, M.D., co-author Les Robison, Ph.D., St. Jude Department of Epidemiology and Cancer Control chair, I-Chang Huang, Ph.D., co-author and K
Pediatrics December 26,2023
Establishment of breast phyllodes tumor cell lines to facilitate future studies

Establishment of breast phyllodes tumor cell lines to facilitate future studies

by Compuscript LtdCredit: CC0 Public DomainBreast phyllodes tumors (PTs) are biphasic, with epithelial and stromal components. Although the PT incidence is low (approximately 1% of all breast tumors),
Oncology December 26,2023
Establishment of breast phyllodes tumor cell lines to facilitate future studies

Establishment of breast phyllodes tumor cell lines to facilitate future studies

by Compuscript LtdCredit: CC0 Public DomainBreast phyllodes tumors (PTs) are biphasic, with epithelial and stromal components. Although the PT incidence is low (approximately 1% of all breast tumors),
Oncology December 26,2023
Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests a simple blood test—administered before CAR-T cell treatment is initiate
Neurology December 26,2023
Simple blood test predicts neurotoxic complications of CAR-T cell therapy

Simple blood test predicts neurotoxic complications of CAR-T cell therapy

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis suggests a simple blood test—administered before CAR-T cell treatment is initiate
Neurology December 26,2023
Simple laser treatments may prevent nonmelanoma skin cancer

Simple laser treatments may prevent nonmelanoma skin cancer

by Katie Marquedant,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainNew research indicates that simple laser treatments to the skin may help to prevent the development of basal ce
Oncology December 26,2023
Simple laser treatments may prevent nonmelanoma skin cancer

Simple laser treatments may prevent nonmelanoma skin cancer

by Katie Marquedant,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainNew research indicates that simple laser treatments to the skin may help to prevent the development of basal ce
Oncology December 26,2023
Simple low-dose aspirin may boost ovarian cancer survival

Simple low-dose aspirin may boost ovarian cancer survival

by QIMR BerghoferCredit: QIMRNew QIMR Berghofer research has found that low-dose aspirin may improve ovarian cancer survival.The study followed more than 900 Australian women newly-diagnosed with&nbsp
Oncology December 26,2023
Simple low-dose aspirin may boost ovarian cancer survival

Simple low-dose aspirin may boost ovarian cancer survival

by QIMR BerghoferCredit: QIMRNew QIMR Berghofer research has found that low-dose aspirin may improve ovarian cancer survival.The study followed more than 900 Australian women newly-diagnosed with&nbsp
Oncology December 26,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com